Course: Improving Identification and Management of Hyperlipidemia in Rural and Underserved Communities
CME Credits: 0.00
Released: 2025-08-29
Hyperlipidemia is the primary contributor to atherosclerotic cardiovascular disease (ASCVD), which remains the leading cause of mortality in the United States and has a high disease burden. Rural populations are disproportionately impacted due to limited access to healthcare, increased prevalence of risk factors, and disparities in treatment. As a result, it is essential for primary care clinicians to tailor lipid-lowering therapies based on individual patient factors to enhance both primary and secondary prevention of cardiovascular events. This on-demand CME/CE activity will review the latest evidence on ASCVD risk assessment, including the role of lipoprotein(a); recommended targets for low-density lipoprotein cholesterol (LDL-C); and current and emerging non-statin treatments for lipid lowering. Experts will also present strategies for improving cardiovascular care and outcomes in rural and underserved communities using a multidisciplinary, patient-centered approach. This enduring activity is a recorded session from Rural Health Clinical Congress Spring 2025 that took place on May 17, 2025.
Upon completion of this activity, participants should be better able to:
View Full Course